KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Raw Materials (2017 - 2025)

LifeMD (LFMD) has disclosed Raw Materials for 8 consecutive years, with $854980.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Raw Materials fell 43.23% year-over-year to $854980.0, compared with a TTM value of $854980.0 through Dec 2025, down 43.23%, and an annual FY2025 reading of $854980.0, down 43.23% over the prior year.
  • Raw Materials was $854980.0 for Q4 2025 at LifeMD, down from $931352.0 in the prior quarter.
  • Across five years, Raw Materials topped out at $1.5 million in Q4 2024 and bottomed at $74056.0 in Q3 2021.
  • Average Raw Materials over 5 years is $888752.6, with a median of $931352.0 recorded in 2025.
  • The sharpest move saw Raw Materials plummeted 69.89% in 2021, then surged 1468.14% in 2022.
  • Year by year, Raw Materials stood at $81427.0 in 2021, then soared by 1468.14% to $1.3 million in 2022, then decreased by 4.7% to $1.2 million in 2023, then increased by 23.77% to $1.5 million in 2024, then plummeted by 43.23% to $854980.0 in 2025.
  • Business Quant data shows Raw Materials for LFMD at $854980.0 in Q4 2025, $931352.0 in Q3 2025, and $876944.0 in Q2 2025.